of interest would challenge professional societies, patient advocacy groups, and other entities that develop clinical practice guidelines to confront the scope and appropriateness of their financial ties with industry, eliminate questionable ties, and prudently manage others (Recommendation 8.1). The next chapter discusses conflicts of interest at the level of institutions.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement